Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for iTeos Therapeutics Inc have a median target of 36.00, with a high estimate of 47.00 and a low estimate of 25.00. The median estimate represents a 220.86% increase from the last price of 11.22.
High | 318.9% | 47.00 |
Med | 220.9% | 36.00 |
Low | 122.8% | 25.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | +17.28% |
Average growth rate | -54.93% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -58.83% |
More ▼